Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

908 Devices Secures $17.5M In Growth Funding

by posted 4months ago 13 views
BOSTON, April 29, 2019-- 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced it has closed $17.5 million in a growth equity funding round. This Series E funding brings the company's total to $70M, making 908 Devices the most well-resourced upstart in the multibillion-dollar mass spectrometry market. The round was led by Northpond Ventures, a global venture capital firm dedicated to science and technology. Northpond's Sharon Kedar, a Co-Founder and Partner at the firm, will join the 908 team as a Board member.

In this article